Matrix metalloproteinase inhibitors in the treatment of arthritis

Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs

Volumn 2, Issue 1, 2000, Pages 16-25

  Clark, I M ^a   Rowan, A D ^a   Cawston, T E ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Arthritis; Cartilage; Collagen; Matrix metalloproteinase; Ro 32 3555

Indexed keywords

AGGRECAN; CGS 27023A; CIPEMASTAT; D 1927; DOXYCYCLINE; MARIMASTAT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; MINOCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PRINOMASTAT; REBIMASTAT; STEROID; TANOMASTAT; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG;

CANCER; CLINICAL TRIAL; DISEASE MODEL; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; NONHUMAN; OSTEOARTHRITIS; PAIN; REVIEW; RHEUMATOID ARTHRITIS; TENDINITIS;

EID: 0034013953     PISSN: 14648474     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)